Rock Creek Pharmaceuticals Inc. (fka RCPIQ)

[curestation]

There's a sell-side analyst at Merrill that has coined the phrase "JasonKolbert-ing a stock". That's where you place a fanciful price target on a (promising) company - say $4 - whose underlying fundamentals point towards insolvency. BUT, since your very own firm provides financing, you sort-of-have-to, you know.... let's just call it the team player approach.

Well done, PhD Kolbert. Well done. Got any other gems, Señor Science? I've got a few bucks and am looking to put some money to work. LOL.